IZALONTAMAB
UNII S8YH2C9NLA

Substance Identification & Data

This profile provides standardized clinical and technical data for Izalontamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S8YH2C9NLA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2559704-24-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S8YH2C9NLA

CAS Registry Number

2559704-24-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IZALONTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C178396

National Cancer Institute reference terminology for clinical and research data.

INN ID

12022

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-273

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Izalontamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IZALONTAMAB

Common Names & Synonyms

ANTI-EGFR/HER3 BISPECIFIC ANTIBODY SI-B001

HER3 X EGFR SI-B001

IMMUNOGLOBULIN G1 (DE-448-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN CLONE HER3.H3 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)3-VL), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER

IZALONTAMAB [INN]

IZALONTAMAB [USAN]

IZALONTAMAB [WHO-DD]